Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 635 composition records across product categories including Construction and building materials, Furniture and furnishings, Cleaning products and household care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of FERRIC OXIDE YELLOW in our catalog (epa_cpdat).
Products
635
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 635 composition records across product categories including Construction and building materials, Furniture and furnishings, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Dye, Pigment, No specific technical function.
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 14 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 0.01 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 11 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 6 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 15 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 2 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: 0.04 mg
US
FDA
openFDA substance registry classifies this ingredient as chemical.
US
FDA
openFDA substance registry classifies this ingredient as concept.